Ostia Sciences Analysis: $2M Raised
What is Ostia Sciences?
Biotech startup developing microbiome-based therapeutics
Funding Category
Seed
Product Features & Capabilities
- Salivaricin 10
- Streptococcus salivarius SALI-10
- Pipeline of microbiome therapies
- Health indications for disease prevention
Other Considerations
Secured over $1 million CAD in seed investment; Finalized IP assignment with the University of Toronto; Developed first prototype for microbiome technology
